Orthocell Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.211x

Orthocell Ltd cash flow conversion efficiency. Based on the latest financial reports, Orthocell Ltd (OCC) has a cash flow conversion efficiency ratio of -0.211x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.07 Million ≈ $-2.17 Million USD) by net assets (AU$14.57 Million ≈ $10.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Orthocell Ltd (2013–2025)

Cash flow conversion efficiency of Orthocell Ltd from 2013 to 2025. This chart illustrates how Orthocell Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Orthocell Ltd for real-time trading data and today's change.

Orthocell Ltd Cash Flow Conversion Ratio Explained

Orthocell Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Orthocell Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orthocell Ltd ranked by their cash flow conversion efficiency. Also see Orthocell Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
San Lien Technology TWO:5493	0.050x
Humanica Public Company Limited BK:HUMAN	0.044x
Minerva Neurosciences Inc NASDAQ:NERV	21.365x
Besiktas Futbol Yatirimlari Sanayi ve Ticaret AS IS:BJKAS	0.286x
Noroo Paint KO:090350	0.064x
Graphite One Inc V:GPH	-0.057x
Nelly Group AB ST:NELLY	-0.064x
Avaco Co. Ltd KQ:083930	0.337x

Annual Cash Flow Conversion Efficiency for Orthocell Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Orthocell Ltd from 2013 to 2025. Review Orthocell Ltd (OCC) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$14.57 Million ≈ $10.31 Million	AU$-8.68 Million ≈ $-6.14 Million	-0.596x	+58.47%
2024-06-30	AU$4.53 Million ≈ $3.21 Million	AU$-6.51 Million ≈ $-4.60 Million	-1.435x	-160.48%
2023-06-30	AU$6.15 Million ≈ $4.35 Million	AU$14.59 Million ≈ $10.33 Million	2.373x	+475.40%
2022-06-30	AU$9.90 Million ≈ $7.01 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.632x	-130.23%
2021-06-30	AU$16.87 Million ≈ $11.94 Million	AU$-4.63 Million ≈ $-3.28 Million	-0.275x	-9.18%
2020-06-30	AU$20.90 Million ≈ $14.79 Million	AU$-5.26 Million ≈ $-3.72 Million	-0.251x	+35.49%
2019-06-30	AU$10.72 Million ≈ $7.59 Million	AU$-4.18 Million ≈ $-2.96 Million	-0.390x	+80.09%
2018-06-30	AU$2.37 Million ≈ $1.68 Million	AU$-4.64 Million ≈ $-3.29 Million	-1.958x	-159.49%
2017-06-30	AU$4.71 Million ≈ $3.33 Million	AU$-3.56 Million ≈ $-2.52 Million	-0.754x	-10.96%
2016-06-30	AU$4.88 Million ≈ $3.46 Million	AU$-3.32 Million ≈ $-2.35 Million	-0.680x	-7.70%
2015-06-30	AU$4.38 Million ≈ $3.10 Million	AU$-2.77 Million ≈ $-1.96 Million	-0.631x	+97.26%
2014-06-30	AU$76.19K ≈ $53.91K	AU$-1.75 Million ≈ $-1.24 Million	-23.009x	-8434.14%
2013-06-30	AU$1.08 Million ≈ $762.57K	AU$-290.57K ≈ $-205.60K	-0.270x	--

About Orthocell Ltd

AU:OCC Australia Biotechnology

Market Cap

$109.42 Million

AU$154.65 Million AUD

Market Cap Rank

#18643 Global

#577 in Australia

Share Price

AU$0.57

Change (1 day)

+0.00%

52-Week Range

AU$0.50 - AU$1.15

All Time High

AU$1.75